ICON

ICON Reports Growth in Revenues, Income and EPS

Thursday, July 23, 2009 06:59 AM

Dublin, Ireland-based ICON gave shareholders a triple dose of good news yesterday with its second quarter 2009 earnings release. Revenues, income and earnings per share were all up compared to last year.  Net revenues increased $1.7 million to $220 million and net income jumped $4 million to $22.8 million or 38 cents per share on a diluted basis.

More... »

ICON Acquires Veeda Laboratories

Thursday, July 9, 2009 08:03 AM

Dublin, Ireland-based contract research organization ICON acquired Veeda Laboratories, a provider of biomarker laboratory services for an undisclosed sum.

More... »

ICON Report Highlights Need for Resources to Meet New Safety Regulations

Wednesday, June 24, 2009 08:59 AM

A new report released by ICON last week says new safety regulations have created a greater demand for resources to ensure those regulations are met.

More... »

ICON Inks Exclusive European Deal with Lilly

Monday, June 15, 2009 07:00 AM

Dublin, Ireland-based contract research organization (CRO) ICON expanded its outsourcing relationship with Eli Lilly and Company last week, as the two companies teamed up in an exclusive strategic partnership in Europe.

More... »

CenterWatch Monthly June 2009

Friday, June 5, 2009 09:17 AM

U.S. Sites Rate Medpace, Kendle, ICON as Top CROs in 2009

More... »

CROs See Brighter Future Despite Cancellations

Monday, May 4, 2009 08:00 AM

Contract research organizations (CROs) continue to feel the adverse effects of cancellations and negative foreign exchange, but their most recent earnings reports show some promise.

More... »

ICON Reports Strong Q1 Earnings, Buys Phase I Unit

Tuesday, April 28, 2009 10:31 AM

Dublin, Ireland-based contract research organization ICON reported strong first quarter net revenues with an increase of 9.2% to $201.3 million compared with the same quarter last year, a 25% hike in profit and hopes to add to that performance by acquiring a 100-bed phase I unit in Omaha, Neb.

More... »

ICON Teams Up with MedAvante for CNS Trials

Monday, March 30, 2009 08:00 AM

Dublin, Ireland-based contract research organization (CRO) ICON is partnering with MedAvante, a provider of psychological rating services, to improve the efficiency and effectiveness of central nervous system (CNS) clinical trials.

More... »

ICON, Kendle Finish Strong 2008 on Soft Side

Monday, March 2, 2009 08:00 AM

It was another quarter of ups and downs for the clinical trial industry as contract research organizations (CROs) struggled through project delays and customer hesitation brought on by the unstable economy. In spite of the challenges, however, two CROs—ICON and Kendle—finished the year on top.

More... »

ICON’s Full-Year Revenues up 37%

Tuesday, February 24, 2009 08:10 AM

ICON posted another quarter of growth and closed out 2008 with revenue growth of 37% to $865 million.  Fourth quarter revenues increased 22% over Q4 2007 to $220 million.

More... »